Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
US11186544B2 · kind B2 · utility
1Cited by
9References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 2018 |
| Grant date | Nov 30, 2021 |
| Priority date | — |
| Expiry date | Jun 8, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to compounds of formula (I), which are formyl peptide 2 (FPR2) receptor agonists and/or formyl peptide 1 (FPR1) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.